Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
ETFs with CPHD as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|1.07%||PowerShares Russell 2000 Pure Growth Portfolio (PXSG)||+3.18 (13.71%)|
|0.43%||iShares Russell 2000 Growth ETF (IWO)||+15.80 (11.67%)|
|0.21%||iShares Russell 2000 ETF (IWM)||+12.22 (10.77%)|
|0.2%||SPDR Russell 2000 ETF (TWOK)||+7.10 (10.60%)|
Company Description (as filed with the SEC)
We are a molecular diagnostics company that develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. Our systems enable fast, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Molecular testing historically has involved a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection. Our easy-to-use systems integrate these steps and analyze complex biological samples in our proprietary test cartridges. We were first to the U.S. market with a Clinical Laboratory Improvement Amendments ("CLIA") moderate complexity categorization for an amplified molecular test and the majority of our products are moderately complex, expanding our market opportunity beyond high complexity laboratories. ... More ...
Where does CPHD fit in the risk graph?
|Annual EPS Est:||$-0.67|
|Quarterly EPS Est:||-0.12|